ARK Genomic Revolution ETF
ARKG
72 hedge funds and large institutions have $105M invested in ARK Genomic Revolution ETF in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 10 reducing their positions, and 8 closing their positions.
210% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 10
125% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 8
19% more capital invested
Capital invested by funds: $88.1M → $105M (+$16.6M)
13% more funds holding
Funds holding: 64 → 72 (+8)
1.03% more ownership
Funds ownership: 21.87% → 22.91% (+1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Stephens Inc
Little Rock,
Arkansas
|
+$2.96M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.72M |
| 3 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$2.33M |
| 4 |
Morgan Stanley
New York
|
+$2.13M |
| 5 |
SCA
Snowden Capital Advisors
New York
|
+$1.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Barometer Capital Management
Toronto,
Ontario, Canada
|
-$2.96M |
| 2 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$1.98M |
| 3 |
LPL Financial
San Diego,
California
|
-$1.5M |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$977K |
| 5 |
CWG
Cornerstone Wealth Group
Huntersville,
North Carolina
|
-$685K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DWM
76
Destination Wealth Management
Walnut Creek,
California
| – | -$11K | -332 | Closed |
|
|
CAM
77
Cresset Asset Management
Chicago,
Illinois
| – | -$8K | -250 | Closed |
|
|
BAM
78
Bruderman Asset Management
Locust Valley,
New York
| – | -$5K | -160 | Closed |
|
79
Fidelity Investments
Boston,
Massachusetts
| – | +$64 | +2 | New |
|
|
HI
80
Human Investing
Lake Oswego,
Oregon
| – | +$417 | +13 | New |
|
ARKG Hedge Fund Activity: Q2 2019 in Review
72 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q2 2019, worth a combined $105M — up 19% from $88.1M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new ARKG positions and 8 closed out — a net gain of 10 holders — while 31 added to existing stakes and 10 trimmed.
The largest buyer was Stephens Inc, adding an estimated $2.96M. The largest seller was Barometer Capital Management, exiting entirely with an estimated $2.96M sold.
- 72 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q2 2019, up from 64 in Q1 2019.
- Funds reported $105M of ARK Genomic Revolution ETF stock for Q2 2019, up 19% quarter-over-quarter.
- 18 funds opened new ARK Genomic Revolution ETF positions in Q2 2019 and 8 closed out, a net change of +10 holders.
- The largest ARK Genomic Revolution ETF buyer in Q2 2019 was Stephens Inc, an estimated $2.96M added.
- The largest ARK Genomic Revolution ETF seller in Q2 2019 was Barometer Capital Management, an estimated $2.96M sold.
Based on aggregated 13F filings for Q2 2019.